Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) is a novel therapeutic target for diabetic complications

✍ Scribed by Xu, X.; Luo, P.; Wang, Y.; Cui, Y.; Miao, L.

• Book ID: 118741948
• Publisher: SAGE Publications
• Year: 2013
• Tongue: English
• Weight: 137 KB
• Volume: 41
• Category: Article
• ISSN: 0300-0605
• DOI: 10.1177/0300060513477004